Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Fulvic acid supplements for metabolic syndrome

Official title: Evaluation of Fulvic Acid Supplementation for the Attenuation of Symptoms Associated With Metabolic Syndrome

Run by Arizona State University · NCT07927283 · Data updated 2026-11-12

This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorArizona State University
Academic / other
Locations1 site (Phoenix, Arizona)
StatusRecruiting
StartedNovember 6, 2026
Main results expectedNovember 15, 2027
Study endsNovember 15, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07927283 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with metabolic syndrome or prediabetes who are not pregnant and are not using multiple obesity, heart disease, thyroid, or cancer medications and who are not current smokers or athletes.

Probably not a fit

Patients for whom fulvic acid does not affect their metabolic markers or who do not tolerate the supplement may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will compare two doses of fulvic acid to placebo over 12 weeks in adults with metabolic syndrome or prediabetes. Participants will receive either 50 mg or 100 mg of fulvic acid daily, or a placebo, to see if the supplement improves metabolic markers and related symptoms. The trial builds on limited prior work and aims to provide controlled data on safety and efficacy in this population. Recruitment is planned at a site in Phoenix, Arizona under the lead sponsorship of Arizona State University. Outcomes will focus on metabolic parameters and markers of metabolic health.

Why it matters

Potential benefit: If successful, participants could experience improvements in metabolic health markers and a possible reduction in risk factors associated with metabolic syndrome.

How similar studies have gone: Limited prior data exist; some nonrandomized studies suggested lipid and antioxidant benefits, but robust randomized evidence is sparse and this trial seeks to provide controlled results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* metabolic syndrome or prediabetes

Exclusion Criteria:

* pregnant or nursing
* multiple medications to treat obesity, heart disease, thyroid conditions, cancer
* smokers
* competing athletes
* vegetarians

Where it's running

  • PBC 850 N 5th Street
    Phoenix, Arizona, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.